Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
(3) Researchers have investigated whether NNMT inhibition might represent a novel approach to modulating energy expenditure and metabolic health
It is supplied by Pliva Pakistan (Pvt) Ltd
Dosing Schedules from Published Research Phase 2 Trial Dose Groups The Phase 2 clinical trial published in NEJM employed the following dose groups, all administered via subcutaneous injection once weekly: Scroll sideways to view the full table on mobile
NNMT inhibition increases availability of NAD+ and influences metabolic processes, allowing the body to burn more calories while suppressing additional glycogen and fat deposits
Frequency is typically once daily for general effects or twice daily for acute conditions, often taken in morning for mental clarity (though timings relevance is unproven)
Supplied in 30mL vials providing sufficient volume for repeated in vitro assay preparation
US$ 24.98
US$ 22.91
US$ 27.30
US$ 20.75
US$ 20.22
